{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:07:21Z","timestamp":1791684441814,"version":"4.3.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T00:00:00Z","timestamp":1700524800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007075","name":"European Society for Medical Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007075","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","thegreenjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.radonc.2023.110019","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T18:55:51Z","timestamp":1700679351000},"page":"110019","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Proton and photon radiotherapy in stage III NSCLC: Effects on hematological toxicity and adjuvant immune therapy"],"prefix":"10.1016","volume":"190","author":[{"given":"Francesco","family":"Cortiula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizza E.L.","family":"Hendriks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Wijsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruud","family":"Houben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Steens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Debakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Canters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Trov\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanna M.","family":"Sijtsema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne G.H.","family":"Niezink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Unipan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Urban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Michelotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safiye","family":"Dursun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerben","family":"Bootsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djoya","family":"Hattu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost J.","family":"Nuyttens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicki T.","family":"Taasti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"De Ruysscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2023.110019_b0005","doi-asserted-by":"crossref","unstructured":"Spigel DR, Faivre-Finn C, Gray JE, et al. Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer. J Clin Oncol. Published online February 2, 2022:JCO2101308. doi:10.1200\/JCO.21.01308.","DOI":"10.1200\/JCO.21.01308"},{"key":"10.1016\/j.radonc.2023.110019_b0010","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1200\/JCO.19.01162","article-title":"Long-term results of NRG oncology RTOG 0617: Standard- versus high-dose chemoradiotherapy with or without cetuximab for unresectable stage III non-small-cell lung cancer","volume":"38","author":"Bradley","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.110019_b0015","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13014-017-0824-x","article-title":"Radiation-related lymphopenia is associated with spleen irradiation dose during radiotherapy in patients with hepatocellular carcinoma","volume":"12","author":"Liu","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.110019_b0020","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.jtho.2020.06.008","article-title":"Radiotherapy-related lymphopenia affects overall survival in patients with lung cancer","volume":"15","author":"Abravan","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2023.110019_b0025","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2307\/3577549","article-title":"Radiosensitivity of CD4 or CD8 positive human T-lymphocytes by an in vitro colony formation assay","volume":"123","author":"Nakamura","year":"1990","journal-title":"Radiat Res"},{"key":"10.1016\/j.radonc.2023.110019_b0030","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/0360-3016(85)90114-2","article-title":"Long term effects on the immune system following local radiation therapy for breast cancer. I. Cellular composition of the peripheral blood lymphocyte population","volume":"11","author":"Rotstein","year":"1985","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.110019_b0035","first-page":"289","article-title":"Distribution of lymphocyte subsets following radiation therapy directed to different body regions","volume":"9","author":"Blomgren","year":"1983","journal-title":"Clin Oncol"},{"key":"10.1016\/j.radonc.2023.110019_b0040","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1172\/JCI108532","article-title":"Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin\u2019s disease","volume":"58","author":"Fuks","year":"1976","journal-title":"J Clin Invest"},{"key":"10.1016\/j.radonc.2023.110019_b0045","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0140-6736(72)91091-4","article-title":"Lymphopenia and change in distribution of human B and T lymphocytes in peripheral blood induced by irradiation for mammary carcinoma","volume":"299","author":"Stjernsw\u00e4rd","year":"1972","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2023.110019_b0050","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ijrobp.2014.04.025","article-title":"Lymphopenia association with gross tumor volume and lung V5 and its effects on non-small cell lung cancer patient outcomes","volume":"89","author":"Tang","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.110019_b0055","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s13277-015-3888-y","article-title":"Radiation-related lymphopenia as a new prognostic factor in limited-stage small cell lung cancer","volume":"37","author":"Cho","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.radonc.2023.110019_b0060","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13014-019-1287-z","article-title":"Treatment-duration is related to changes in peripheral lymphocyte counts during definitive radiotherapy for unresectable stage III NSCLC","volume":"14","author":"Zhao","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.110019_b0065","article-title":"Impact of lymphopenia recovery after chemoradiotherapy on durvalumab consolidation therapy in stage III non-small cell lung cancer","author":"Kuge","year":"2023","journal-title":"JTO Clin Res Rep"},{"key":"10.1016\/j.radonc.2023.110019_b0070","article-title":"Severe radiation-induced lymphopenia attenuates the benefit of durvalumab after concurrent chemoradiotherapy for NSCLC","volume":"3","author":"Jing","year":"2022","journal-title":"JTO Clin Res Rep"},{"key":"10.1016\/j.radonc.2023.110019_b0075","first-page":"216","article-title":"Ion beam radiobiology and cancer: time to update ourselves","volume":"1796","author":"Fokas","year":"2009","journal-title":"BBA"},{"key":"10.1016\/j.radonc.2023.110019_b0080","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ijrobp.2014.07.045","article-title":"Clinical implementation of intensity modulated proton therapy for thoracic malignancies","volume":"90","author":"Chang","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.110019_b0085","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.adro.2018.09.004","article-title":"A comparison of grade 4 lymphopenia with proton versus photon radiation therapy for esophageal cancer","volume":"4","author":"Routman","year":"2019","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.110019_b0090","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.2032","article-title":"Proton beam radiotherapy and concurrent chemotherapy for unresectable stage III non-small cell lung cancer","volume":"3","author":"Chang","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2023.110019_b0095","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.radonc.2015.05.014","article-title":"Long-term outcomes after proton therapy, with concurrent chemotherapy, for stage II-III inoperable non-small cell lung cancer","volume":"115","author":"Nguyen","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.110019_b0100","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.radonc.2019.03.029","article-title":"Clinical outcomes after intensity-modulated proton therapy with concurrent chemotherapy for inoperable non-small cell lung cancer","volume":"136","author":"Elhammali","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.110019_b0105","unstructured":"Amin M.B., Edge S., Greene F., et al. AJCC Cancer Staging Manual (8th Edition). Springer International Publishing: American Joint Commission on Cancer; 2017."},{"key":"10.1016\/j.radonc.2023.110019_b0110","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.ijrobp.2020.04.011","article-title":"A systematic review of contouring guidelines in radiation oncology: Analysis of frequency, methodology, and delivery of consensus recommendations","volume":"107","author":"Lin","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.110019_b0115","doi-asserted-by":"crossref","first-page":"20190879","DOI":"10.1259\/bjr.20190879","article-title":"Photons or protons for reirradiation in (non-)small cell lung cancer: Results of the multicentric ROCOCO in silico study","volume":"93","author":"Troost","year":"2020","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2023.110019_b0120","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.radonc.2013.05.007","article-title":"Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach","volume":"107","author":"Langendijk","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.110019_b0125","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1037\/a0014268","article-title":"Average causal effects from nonrandomized studies: a practical guide and simulated example","volume":"13","author":"Schafer","year":"2008","journal-title":"Psychol Methods"},{"key":"10.1016\/j.radonc.2023.110019_b0130","first-page":"121","article-title":"Radiation sensitivity of human and murine peripheral blood lymphocytes, stem and progenitor cells","volume":"1846","author":"Heylmann","year":"2014","journal-title":"BBA"},{"key":"10.1016\/j.radonc.2023.110019_b0135","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1038\/s41598-021-81058-1","article-title":"Comparison of DNA repair and radiosensitivity of different blood cell populations","volume":"11","author":"Heylmann","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.radonc.2023.110019_b0140","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/0360-3016(83)90008-1","article-title":"The effects of conventionally fractionated, extended portal radiotherapy on the human peripheral blood count","volume":"9","author":"Plowman","year":"1983","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.110019_b0145","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fimmu.2016.00020","article-title":"T cells and cancer: How metabolism shapes immunity","volume":"7","author":"Molon","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.radonc.2023.110019_b0150","first-page":"180","article-title":"Chemo\/radiotherapy-induced bone marrow niche alterations","volume":"39","author":"Rafieemehr","year":"2021","journal-title":"Cancer Invest"},{"key":"10.1016\/j.radonc.2023.110019_b0155","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/BF00184787","article-title":"Distribution of lymphocyte subsets and natural killer cells in the human body","volume":"70","author":"Westermann","year":"1992","journal-title":"Clin Investig"},{"key":"10.1016\/j.radonc.2023.110019_b0160","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3390\/curroncol28010089","article-title":"Total body irradiation for hematopoietic stem cell transplantation: What can we agree on?","volume":"28","author":"Sabloff","year":"2021","journal-title":"Curr Oncol"},{"key":"10.1016\/j.radonc.2023.110019_b0165","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/00005373-199312000-00007","article-title":"Lymphocyte subset responses to trauma and sepsis","volume":"35","author":"Cheadle","year":"1993","journal-title":"J Trauma"},{"key":"10.1016\/j.radonc.2023.110019_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2022.06.013","article-title":"Immunotherapy in unresectable stage III non-small-cell lung cancer: state of the art and novel therapeutic approaches","author":"Cortiula","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2023.110019_b0175","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature10673","article-title":"Cancer immunotherapy comes of age","volume":"480","author":"Mellman","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.radonc.2023.110019_b0180","doi-asserted-by":"crossref","unstructured":"Aleman BMP, van den Belt-Dusebout AW, Klokman WJ, Van\u2019t Veer MB, Bartelink H, van Leeuwen FE. Long-term cause-specific mortality of patients treated for Hodgkin\u2019s disease. J Clin Oncol. 2003;21:3431-3439. doi:10.1200\/JCO.2003.07.131.","DOI":"10.1200\/JCO.2003.07.131"},{"key":"10.1016\/j.radonc.2023.110019_b0185","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.radonc.2008.01.012","article-title":"Randomized controlled trials in health technology assessment: overkill or overdue?","volume":"86","author":"Bentzen","year":"2008","journal-title":"Radiother Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402309326X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402309326X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T09:09:18Z","timestamp":1734253758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016781402309326X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":37,"alternative-id":["S016781402309326X"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2023.110019","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proton and photon radiotherapy in stage III NSCLC: Effects on hematological toxicity and adjuvant immune therapy","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2023.110019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110019"}}